Essex Investment Management CO LLC Eye Point Pharmaceuticals, Inc. Transaction History
Essex Investment Management CO LLC
- $536 Million
- Q3 2024
A detailed history of Essex Investment Management CO LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Essex Investment Management CO LLC holds 142,144 shares of EYPT stock, worth $1.19 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
142,144
Previous 42,538
234.16%
Holding current value
$1.19 Million
Previous $370,000
206.76%
% of portfolio
0.21%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding EYPT
# of Institutions
151Shares Held
58MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$69.4 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$43.2 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$33.5 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$31.6 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$31.4 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $284M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...